AGT and cardiac hypertrophy: Western blot analysis revealed that Ang II treatment markedly suppressed the expression of pAMPK and SIRT1 proteins in cardiomyocytes, which was accompanied by an upregulation of the cardiac hypertrophy marker BNP (Figure 5D–G).